Pharmaceutical company Dr Reddy's Laboratories today said that its consolidated net profit declined by 14.28 per cent to Rs 209.55 crore for the first quarter ended June 30, over the same period in the previous fiscal.
Net income from sales and services stood at Rs 1,683.13 crore, compared to Rs 1,818.94 crore in the same period of the corresponding fiscal, Dr Reddy's said in a filing to the Bombay Stock Exchange (BSE).
During the quarter, the company launched 32 new products and filed 25 new product registrations, it added.
The company, during the quarter, also transferred dossiers and trademarks for nine currently marketed products in Brazil to GSK, for a consideration of $4 million.
Shares of Dr Reddy's Laboratories today closed at Rs 1,380.60 on the BSE, down 1.69 per cent from its previous close.
